We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-6.19%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.45B
AUM Growth
-$1.58B
(-52%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-102.26%
Top 10 Holdings %
Top 10 Hldgs %
47.63%
Holding
45
New
7
Increased
12
Reduced
10
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$49.6M |
| 2 |
DexCom
DXCM
|
+$37.1M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$32.2M |
| 4 |
Nektar Therapeutics
NKTR
|
+$25M |
| 5 |
Tenet Healthcare
THC
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$45.4M |
| 2 |
Centene
CNC
|
+$42.4M |
| 3 |
DYAX
DYAX CORPORATION
DYAX
|
+$37M |
| 4 |
SHPG
Shire pic
SHPG
|
+$28.9M |
| 5 |
UnitedHealth
UNH
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.74% |
| 2 | Consumer Discretionary | 10.62% |
| 3 | Communication Services | 9.85% |
| 4 | Industrials | 6.79% |
| 5 | Consumer Staples | 5.29% |
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2016 Portfolio in Review
As of Q1 2016, Bridger Management held 45 positions worth $1.45B, down 52% from $3.03B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Bridger Management withdrew a net $1.48B in Q1 2016, closing 5 positions and reducing 10 holdings. Its most notable exit was DYAX CORPORATION, an estimated $37M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Bridger Management opened a new position in St Jude Medical worth $50.1M.
- Bridger Management's largest Q1 2016 buy was St Jude Medical: 911,008 shares worth $50.1M.
- Bridger Management added most to DexCom in Q1 2016, an estimated $37.1M increase.
- Bridger Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $45.4M.
- Bridger Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $37M.
- Bridger Management's ten largest holdings make up 48% of its $1.45B portfolio in Q1 2016.
- Bridger Management opened 7 new positions and closed 5 in Q1 2016.
- Bridger Management's portfolio value fell 52% quarter-over-quarter to $1.45B.
Based on Bridger Management's 13F filing for Q1 2016, filed 16 May 2016.